Search research articles
Contact Us
Filters
Showing results (231-240 of 358) with videos related to
Page
of 36
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 1, 2023
A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
Mark Weiser, Linda Levi, Jinyoung Park, et al.
Schizophrenia Research
|
October 23, 2012
Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia
Emma E M Knowles, Mark Weiser, Anthony S David, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 4, 2025
The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
Nini de Boer, Zara Vučko, Derek Ij Koster, et al.
International Journal of Cardiology
|
February 7, 2012
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia
Fabian Chen, Darbie Maccubbin, Lizhen Yan, et al.
The American Journal of Psychiatry
|
November 29, 2017
A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis
Abigail Livny, Abraham Reichenberg, Eyal Fruchter, et al.
Journal of the American College of Cardiology
|
April 12, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation
John D Brunzell, Michael Davidson, Curt D Furberg, et al.
Schizophrenia Research
|
November 21, 2008
Refractive errors and schizophrenia
Asaf Caspi, Tali Vishne, Abraham Reichenberg, et al.
JAMA Cardiology
|
November 30, 2022
Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial
Nicholas H Adamstein, Jan Hein Cornel, Michael Davidson, et al.
Circulation
|
April 17, 2008
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus
Michael Davidson, Peter M Meyer, Steven Haffner, et al.
Schizophrenia Research
|
October 23, 2015
A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ
Mark Weiser, Ori Kapra, Nomi Werbeloff, et al.
Page
of 36
Search research articles
Search
Showing results (231-240 of 358) with videos related to
Sort By:
Page
of 36
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 1, 2023
A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
Mark Weiser, Linda Levi, Jinyoung Park, et al.
Schizophrenia Research
|
October 23, 2012
Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia
Emma E M Knowles, Mark Weiser, Anthony S David, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 4, 2025
The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
Nini de Boer, Zara Vučko, Derek Ij Koster, et al.
International Journal of Cardiology
|
February 7, 2012
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia
Fabian Chen, Darbie Maccubbin, Lizhen Yan, et al.
The American Journal of Psychiatry
|
November 29, 2017
A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis
Abigail Livny, Abraham Reichenberg, Eyal Fruchter, et al.
Journal of the American College of Cardiology
|
April 12, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation
John D Brunzell, Michael Davidson, Curt D Furberg, et al.
Schizophrenia Research
|
November 21, 2008
Refractive errors and schizophrenia
Asaf Caspi, Tali Vishne, Abraham Reichenberg, et al.
JAMA Cardiology
|
November 30, 2022
Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial
Nicholas H Adamstein, Jan Hein Cornel, Michael Davidson, et al.
Circulation
|
April 17, 2008
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus
Michael Davidson, Peter M Meyer, Steven Haffner, et al.
Schizophrenia Research
|
October 23, 2015
A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ
Mark Weiser, Ori Kapra, Nomi Werbeloff, et al.
Page
of 36